An allergy is friendly fire
An allergy is your immune system attacking something harmless. Parker and colleagues describe the sequence: a first exposure primes mast cells with IgE antibody, and a later exposure makes those cells dump histamine and other mediators within minutes. The surprise is that the same IgE machinery may also help defend against worms and venoms.
What an allergy is
Parker and colleagues classify allergy as a type I hypersensitivity. A harmless antigen — pollen, dander, mold — is called an allergen. In a susceptible person the first contact drives T helper 2 cells to release IL-4 and IL-13, which push B cells to switch from IgM to IgE. The IgE tail, the Fc region, docks on mast cells. Parker and colleagues cite an estimate that one mast cell can hold up to 500,000 IgE molecules.
Primed, then fired
On that first exposure the allergen is usually gone before IgE is ready, so nothing happens. The cell is merely sensitized. On a later contact, allergen molecules bridge several IgE antibodies at once. Parker and colleagues call this cross-linking; it triggers degranulation, the release of granule contents. Histamine, serotonin and bradykinin come out first, then newly made leukotrienes and prostaglandins. Histamine drives mucus, tears, itching and sneezing; other mediators cause hives, swelling and narrowed bronchioles. Vitte and colleagues note the mediators appear within minutes, with lipid mediators following within about 15 minutes.
Not every allergen fires equally
Hazebrouck, Canon and Dreskin separate sensitizing from eliciting. A protein that generates IgE may not be the one that triggers the reaction. For peanut, they report that two proteins, Ara h 2 and Ara h 6, supply 70–90% of the effector activity, even though other peanut proteins bind plenty of IgE. Effector strength depends on how much specific IgE is present, the ratio of specific to total IgE, receptor numbers on the cell, antibody affinity, and the spacing of IgE-binding sites on the allergen.
Why the machinery might exist
Parker and colleagues reason that a harmful inherited trait would be expected to fade under selection, so type I reactions may have an adaptive role. They cite evidence that the IgE made in these reactions is meant to counter helminths, which are parasitic worms, and that helminth infection early in life lowers the chance of these reactions later. Allergies, they suggest, may be an unfortunate side effect of strong selection for defense against worms. Vitte and colleagues list beneficial roles for IgE-driven reactions against parasites, venoms and toxins, and credit the wider Th2 response with helping repair injured tissue. They also note mast cell proteases can degrade venom peptides. Vitte and colleagues, writing in 2022, put the share of people with allergies at up to 30% in Western countries.
Interactive Set how many IgE antibodies on the mast cell are specific for the allergen, then add allergen and see how many get bridged.
It is not only IgE
Vitte and colleagues stress that IgE is not the whole story. IgG can drive reactions to some drugs when both antibody and allergen are at high concentration, acting through neutrophils and platelets and releasing platelet-activating factor rather than histamine. Complement fragments C3a and C5a can make rat mast cells release histamine, though whether C5a does so in human mast cells is somewhat disputed. A receptor called MRGPRX2 lets mast cells respond to many basic compounds without any IgE. The authors noted in 2022 that a tryptase test cannot separate an IgE-driven reaction from one driven through MRGPRX2.
In short
The reaction is real immune output aimed at a target that poses no threat. IgE arms mast cells, cross-linking fires them, and the same system appears to do useful work against worms and venoms.
Where this comes from
- Microbiology, 19.1 Hypersensitivities (OpenStax) linked only, not reproduced
openstax.org/books/microbiology/pages/19-1-hypersensitivities - Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond (Med Princ Pract 31(6):501-515) linked only, not reproduced
pmc.ncbi.nlm.nih.gov/articles/PMC9841766/ - The Effector Function of Allergens (Front. Allergy 3:818732) linked only, not reproduced
www.frontiersin.org/journals/allergy/articles/10.3389/falgy.2022.818732/full